{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:08:50Z","timestamp":1791328130273,"version":"4.3.1"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["EVOCAN"],"award-info":[{"award-number":["EVOCAN"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3234-4","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T03:44:30Z","timestamp":1491968670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Infections and cancer: the \u201cfifty shades of immunity\u201d hypothesis"],"prefix":"10.1186","volume":"17","author":[{"given":"Camille","family":"Jacqueline","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Tasiemski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Sorci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Ujvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Maachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Miss\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,12]]},"reference":[{"key":"3234_CR1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/j.seminoncol.2014.10.003","volume":"41","author":"H Zur Hausen","year":"2015","unstructured":"Zur Hausen H, Villiers ED. Cancer \u2018causation\u2019 by infections\u2014individual contributions and synergistic networks. Semin Oncol. 2015;41:860\u201375.","journal-title":"Semin Oncol"},{"key":"3234_CR2","doi-asserted-by":"publisher","unstructured":"S\u00f6derlund-Strand, A., Uhnoo, I. & Dillner, J. Change in Population Prevalences of Human Papillomavirus after Initiation of Vaccination: The High-Throughput HPV Monitoring Study. Cancer Epidemiol Biomarkers Prev. 2014; 2757\u20132765. doi: 10.1158\/1055-9965 .EPI-14-0687","DOI":"10.1158\/1055-9965"},{"key":"3234_CR3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.mt.6300108","volume":"15","author":"E Kelly","year":"2007","unstructured":"Kelly E, Russell SJ. History of Oncolytic Viruses\u00a0: genesis to genetic engineering. Mol Ther. 2007;15:651\u20139.","journal-title":"Mol Ther"},{"key":"3234_CR4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","volume":"22","author":"GP Dunn","year":"2004","unstructured":"Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol. 2004;22:329\u201360.","journal-title":"Annu Rev Immunol"},{"key":"3234_CR5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pt.2009.03.001","volume":"25","author":"N Mideo","year":"2009","unstructured":"Mideo N. Parasite adaptations to within-host competition. Trends Parasitol. 2009;25:261\u20138.","journal-title":"Trends Parasitol"},{"key":"3234_CR6","first-page":"795","volume":"80","author":"S Gupta","year":"1998","unstructured":"Gupta S, Ferguson N, Anderson R. Chaos, persistence, and evolution of strain structure in Antigenically diverse infectious agents. Science. 1998;80:795.","journal-title":"Science"},{"key":"3234_CR7","doi-asserted-by":"crossref","unstructured":"Poulin R, Morand S. The Diversity of Parasites. The Quarterly Review of Biology. 2000;75:277\u2013293.","DOI":"10.1086\/393500"},{"key":"3234_CR8","doi-asserted-by":"crossref","DOI":"10.1515\/9781400840809","volume-title":"Evolutionary ecology of parasites","author":"R Poulin","year":"2007","unstructured":"Poulin R. Evolutionary ecology of parasites. 2nd ed. Princeton: Princet. Univ. Press; 2007.","edition":"2"},{"key":"3234_CR9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","volume":"29","author":"MD Vesely","year":"2011","unstructured":"Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol. 2011;29:235\u201371.","journal-title":"Annu Rev Immunol"},{"key":"3234_CR10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.coi.2010.02.006","volume":"22","author":"G Bindea","year":"2010","unstructured":"Bindea G, Mlecnik B, Fridman WH, Pag\u00e8s F, Galon J. Natural immunity to cancer in humans. Curr Opin Immunol. 2010;22:215\u201322.","journal-title":"Curr Opin Immunol"},{"key":"3234_CR11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883\u201399.","journal-title":"Cell"},{"key":"3234_CR12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Review hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"3234_CR13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3332\/ecancer.2014.486","volume":"8","author":"A Ingels","year":"2014","unstructured":"Ingels A, et al. T-helper 1 immunoreaction influences survival in muscle-invasive bladder cancer: proof of concept. Ecancermedicalscience. 2014;8:486.","journal-title":"Ecancermedicalscience"},{"key":"3234_CR14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ncomms1239","volume":"2","author":"OAW Haabeth","year":"2011","unstructured":"Haabeth OAW, et al. Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nat Commun. 2011;2:240.","journal-title":"Nat Commun"},{"key":"3234_CR15","doi-asserted-by":"crossref","first-page":"14010","DOI":"10.1073\/pnas.0903225106","volume":"106","author":"LA Vella","year":"2009","unstructured":"Vella LA, et al. Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer. Proc Natl Acad Sci U S A. 2009;106:14010\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3234_CR16","first-page":"223","volume":"8","author":"P Kidd","year":"2003","unstructured":"Kidd P. Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8:223\u201346.","journal-title":"Altern Med Rev"},{"key":"3234_CR17","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","volume":"14","author":"BE Lippitz","year":"2013","unstructured":"Lippitz BE. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol. 2013;14:e218\u201328.","journal-title":"Lancet Oncol"},{"key":"3234_CR18","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","volume":"40","author":"A Kimura","year":"2010","unstructured":"Kimura A, Kishimoto T. IL-6: regulator of Treg\/Th17 balance. Eur J Immunol. 2010;40:1830\u20135.","journal-title":"Eur J Immunol"},{"key":"3234_CR19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.it.2009.09.002","volume":"30","author":"H Zaghouani","year":"2009","unstructured":"Zaghouani H, Hoeman CM, Adkins B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol. 2009;30:585\u201391.","journal-title":"Trends Immunol"},{"key":"3234_CR20","volume-title":"The immune system in health and disease","author":"CA Janeway","year":"2001","unstructured":"Janeway, C. A., Travers, P., Walport, M. & Shlomchik, M. J. The immune system in health and disease. (2001)."},{"key":"3234_CR21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s10552-010-9546-1","volume":"21","author":"DW Cramer","year":"2011","unstructured":"Cramer DW, Ave L. Mumps and ovarian cancer: moder interpretation of an historic association. Cancer Causes Control. 2011;21:1193\u2013201.","journal-title":"Cancer Causes Control"},{"key":"3234_CR22","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0277-9536(00)00230-6","volume":"52","author":"DL Blackwell","year":"2001","unstructured":"Blackwell DL, Hayward MD, Crimmins EM. Does childhood health affect chronic morbidity in later life? Soc Sci Med. 2001;52:1269\u201384.","journal-title":"Soc Sci Med"},{"key":"3234_CR23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc1816","volume":"6","author":"M Greaves","year":"2006","unstructured":"Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6:193\u2013203.","journal-title":"Nat Rev Cancer"},{"key":"3234_CR24","doi-asserted-by":"publisher","unstructured":"Ma, X. et al. Daycare attendance and risk of childhood acute lymphoblastic leukaemia. 2003 1419\u20131424. doi: 10.1038\/sj\/bjc\/6600274","DOI":"10.1038\/sj\/bjc\/6600274"},{"key":"3234_CR25","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/ijc.28205","volume":"133","author":"S Parodi","year":"2013","unstructured":"Parodi S, et al. Childhood infectious diseases and risk of leukaemia in an adult population. Int J Cancer. 2013;133:1892\u20139.","journal-title":"Int J Cancer"},{"key":"3234_CR26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/aje\/kws180","volume":"176","author":"S Crouch","year":"2012","unstructured":"Crouch S, et al. Infectious illness in children subsequently diagnosed with acute lymphoblastic leukemia: modeling the trends from birth to diagnosis. Am J Epidemiol. 2012;176:402\u20138.","journal-title":"Am J Epidemiol"},{"key":"3234_CR27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/aje\/kwi138","volume":"161","author":"G Mastrangelo","year":"2005","unstructured":"Mastrangelo G, et al. Lung cancer risk: effect of dairy farming and the consequence of removing that occupational exposure. Am J Epidemiol. 2005;161:1037\u201346.","journal-title":"Am J Epidemiol"},{"key":"3234_CR28","first-page":"241","volume":"8","author":"R Rylander","year":"2002","unstructured":"Rylander R. Endotoxin in the environment--exposure and effects. J Endotoxin Res. 2002;8:241\u201352.","journal-title":"J Endotoxin Res"},{"key":"3234_CR29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1158\/2326-6066.CIR-13-0125","volume":"2","author":"UK Iheagwara","year":"2015","unstructured":"Iheagwara UK, et al. Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor associated antigens: a new view of cancer immunosurveillance. Cancer Immunol Res. 2015;2:263\u201373.","journal-title":"Cancer Immunol Res"},{"key":"3234_CR30","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood-2006-08-044008","volume":"109","author":"O Landgren","year":"2007","unstructured":"Landgren O, Rapkin J. Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood. 2007;109:2198\u2013201.","journal-title":"Blood"},{"key":"3234_CR31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2141.2009.07849.x","volume":"147","author":"L Anderson","year":"2010","unstructured":"Anderson L, Landgren O, Engels E. Commun community acquired infections and subsequent risk of chronic lymphocytic leukemia. Br J Haematol. 2010;147:444\u20139.","journal-title":"Br J Haematol"},{"key":"3234_CR32","volume-title":"Immunodepression and Immunosuppression during aging","author":"V Thomas-vaslin","year":"2009","unstructured":"Thomas-vaslin, V. et al. Immunodepression and Immunosuppression during aging. (2009)."},{"key":"3234_CR33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1749-6632.2009.05370.x","volume":"1197","author":"T Fulop","year":"2010","unstructured":"Fulop T, et al. Potential role of immunosenescence in cancer development. Ann N Y Acad Sci. 2010;1197:158\u201365.","journal-title":"Ann N Y Acad Sci"},{"key":"3234_CR34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mad.2008.06.003","volume":"130","author":"S Vasto","year":"2009","unstructured":"Vasto S, et al. Inflammation, ageing and cancer. Mech Ageing Dev. 2009;130:40\u20135.","journal-title":"Mech Ageing Dev"},{"key":"3234_CR35","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/bies.200900025","volume":"31","author":"U Hobohm","year":"2009","unstructured":"Hobohm U. Toward general prophylactic cancer vaccination. BioEssays. 2009;31:1071\u20139.","journal-title":"BioEssays"},{"key":"3234_CR36","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.mayocp.2014.04.003","volume":"89","author":"SJ Russell","year":"2014","unstructured":"Russell SJ, et al. Remission of disseminated cancer after systemic oncolytic virotherapy. Mayo Clin Proc. 2014;89:926\u201333.","journal-title":"Mayo Clin Proc"},{"key":"3234_CR37","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM, et al. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet. 2012;379:1591\u2013601.","journal-title":"Lancet"},{"key":"3234_CR38","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.18.4.767","author":"T Efferth","year":"2001","unstructured":"Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar C. The anti-malarial artesunate is also active against cancer. Int J Oncol. 2001; doi: 10.3892\/ijo.18.4.767 .","journal-title":"Int J Oncol"},{"key":"3234_CR39","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.18632\/oncotarget.3174","volume":"6","author":"R Lamb","year":"2015","unstructured":"Lamb R, et al. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease. Oncotarget. 2015;6:4569\u201384.","journal-title":"Oncotarget"},{"key":"3234_CR40","doi-asserted-by":"crossref","first-page":"6950","DOI":"10.1016\/j.vaccine.2009.08.103","volume":"27","author":"M Villumsen","year":"2009","unstructured":"Villumsen M, et al. Risk of lymphoma and leukaemia after bacille Calmette-Gu\u00e9rin and smallpox vaccination: a Danish case-cohort study. Vaccine. 2009;27:6950\u20138.","journal-title":"Vaccine"},{"key":"3234_CR41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.vaccine.2008.10.076","volume":"27","author":"G Mastrangelo","year":"2009","unstructured":"Mastrangelo G, et al. Does yellow fever 17D vaccine protect against melanoma? Vaccine. 2009;27:588\u201391.","journal-title":"Vaccine"},{"key":"3234_CR42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1258\/jrsm.96.8.389","volume":"96","author":"JM Grange","year":"2003","unstructured":"Grange JM, Stanford JL, Stanford CA, Ko KF. Vaccination strategies to reduce the risk of leukemia and melanoma. J R Soc Med. 2003;96:389\u201392.","journal-title":"J R Soc Med"},{"key":"3234_CR43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejca.2004.08.010","volume":"41","author":"B Krone","year":"2005","unstructured":"Krone B, K\u00f6lmel KF, Henz BM, Grange JM. Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and\/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control. Eur J Cancer. 2005;41:104\u201317.","journal-title":"Eur J Cancer"},{"key":"3234_CR44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejca.2004.09.023","volume":"41","author":"KF K\u00f6lmel","year":"2005","unstructured":"K\u00f6lmel KF, et al. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of cancer cohort study on 542 patients. Eur J Cancer. 2005;41:118\u201325.","journal-title":"Eur J Cancer"},{"key":"3234_CR45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tree.2006.11.005","volume":"22","author":"AB Pedersen","year":"2007","unstructured":"Pedersen AB, Fenton A. Emphasizing the ecology in parasite community ecology. Trends Ecol Evol. 2007;22:133\u20139.","journal-title":"Trends Ecol Evol"},{"issue":"Suppl 3","key":"3234_CR46","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1086\/651492","volume":"50","author":"H Getahun","year":"2010","unstructured":"Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010;50(Suppl 3):S201\u20137.","journal-title":"Clin Infect Dis"},{"key":"3234_CR47","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature01542","volume":"1979","author":"P Rohani","year":"2003","unstructured":"Rohani P, Green CJ, Mantilla-Beniers NB, Grenfell BT. Ecological interference between fatal diseases. Nature. 2003;1979:885\u20138.","journal-title":"Nature"},{"key":"3234_CR48","first-page":"667","volume-title":"Epstein-Barr virus-malaria interaction models for Burkitt \u2019 s lymphoma: implications for preventive trials Epstein-Barr virus-malaria interaction models for Burkitt \u2019 s lymphoma: implications for preventive trials 1","author":"RH Morrow","year":"1976","unstructured":"Morrow RH, Gutensohn N, Smith PG. Epstein-Barr virus-malaria interaction models for Burkitt \u2019 s lymphoma: implications for preventive trials Epstein-Barr virus-malaria interaction models for Burkitt \u2019 s lymphoma: implications for preventive trials 1; 1976. p. 667\u20139."},{"key":"3234_CR49","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/QCO.0b013e328349ac4f","volume":"24","author":"AM Moormann","year":"2011","unstructured":"Moormann AM, Snider CJ, Chelimo K. The company malaria keeps\u00a0: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma. Curr Opin Infect Dis. 2011;24:435\u201341.","journal-title":"Curr Opin Infect Dis"},{"key":"3234_CR50","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1371\/journal.ppat.0030080","volume":"3","author":"A Ch\u00eane","year":"2007","unstructured":"Ch\u00eane A, et al. A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathog. 2007;3:e80.","journal-title":"PLoS Pathog"},{"key":"3234_CR51","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nri1201","volume":"3","author":"R K\u00fcppers","year":"2003","unstructured":"K\u00fcppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol. 2003;3:801\u201312.","journal-title":"Nat. Rev. Immunol."},{"key":"3234_CR52","first-page":"625","volume":"5","author":"JN Dups","year":"2014","unstructured":"Dups JN, Pepper M, Cockburn IA. Antibody and B cell responses to Plasmodium sporozoites. Front Microbiol. 2014;5:625.","journal-title":"Front Microbiol"},{"key":"3234_CR53","first-page":"2621","volume":"125","author":"MM Madeleine","year":"2013","unstructured":"Madeleine MM, et al. NIH public access. Int J Cancer. 2013;125:2621\u20139.","journal-title":"Int J Cancer"},{"key":"3234_CR54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ijc.20970","volume":"116","author":"I Silins","year":"2005","unstructured":"Silins I, et al. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer. 2005;116:110\u20135.","journal-title":"Int J Cancer"},{"key":"3234_CR55","first-page":"4017","volume":"73","author":"EY Fukuda","year":"2005","unstructured":"Fukuda EY, et al. Activation of lipid metabolism contributes to interleukin-8 production during. Society. 2005;73:4017\u201324.","journal-title":"Society"},{"key":"3234_CR56","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4049\/jimmunol.168.5.2255","volume":"168","author":"H Harizi","year":"2002","unstructured":"Harizi H, Juzan M, Pitard V, Moreau J-F, Gualde N. Cyclooxygenase-2-issued prostaglandin E2 enhances the production of endogenous IL-10 which down-regulates Dendritic cell functions. J Immunol. 2002;168:2255\u201363.","journal-title":"J Immunol"},{"key":"3234_CR57","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/humupd\/2.6.519","volume":"2","author":"J Paavonen","year":"1996","unstructured":"Paavonen J, Lehtinen M. Chlamydial pelvic inflammatory disease in adolescents. Hum Reprod Update. 1996;2:519\u201329.","journal-title":"Hum Reprod Update"},{"key":"3234_CR58","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.3201\/eid2110.150881","volume":"21","author":"P Gautret","year":"2015","unstructured":"Gautret P, et al. Local and international implications of Schistosomiasis acquired in Corsica France. Emerg Infect Dis. 2015;21:1865\u20138.","journal-title":"Emerg Infect Dis"},{"key":"3234_CR59","unstructured":"IARC. IARC monographs on the evaluation of carcinogenic risks to humans Schistosomes, Liver Flukes and Helicobacter pylori. Volume 61. 1994."},{"key":"3234_CR60","doi-asserted-by":"crossref","unstructured":"Ossai OP, et al. Bacteriuria and urinary schistosomiasis in primary school children in rural communities in Enugu State, Nigeria, 2012. Pan Afr Med J. 2014;18:4\u20138.","DOI":"10.11604\/pamj.supp.2014.18.1.4169"},{"key":"3234_CR61","first-page":"103","volume":"5","author":"OA Adeyeba","year":"2002","unstructured":"Adeyeba OA, Ojeaga SGT. Urinary Schistosomiasis and concomitant urinary tract pathogens among school children in metropolitan Ibadan. Afr J Biomed Res. 2002;5:103\u20138.","journal-title":"Afr J Biomed Res"},{"key":"3234_CR62","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1128\/IAI.01578-13","volume":"82","author":"Y-J Hsieh","year":"2014","unstructured":"Hsieh Y-J, Fu C-L, Hsieh MH. Helminth-induced interleukin-4 abrogates invariant natural killer T cell activation-associated clearance of bacterial infection. Infect Immun. 2014;82:2087\u201397.","journal-title":"Infect Immun"},{"key":"3234_CR63","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0022-5347(17)49992-7","volume":"132","author":"CP Davis","year":"1984","unstructured":"Davis CP, Cohen MS, Gruber MB, Anderson MD, Warren MM. Urothelial hyperplasia and neoplasia: a response to chronic urinary tract infection in rats. J Urol. 1984;132:1025\u201331.","journal-title":"J Urol"},{"key":"3234_CR64","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbrc.2011.09.073","volume":"414","author":"N Ma","year":"2011","unstructured":"Ma N, et al. Nitrative DNA damage and Oct3\/4 expression in urinary bladder cancer with Schistosoma haematobium infection. Biochem Biophys Res Commun. 2011;414:344\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"3234_CR65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1600-0676.2000.020004281.x","volume":"20","author":"S Kamal","year":"2000","unstructured":"Kamal S, et al. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver. 2000;20:281\u20139.","journal-title":"Liver"},{"key":"3234_CR66","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1086\/323352","volume":"184","author":"SM Kamal","year":"2001","unstructured":"Kamal SM, et al. Specific cellular immune response and cytokine patterns in patients Coinfected with hepatitis C virus and Schistosoma mansoni. J Infect Dis. 2001;184:972\u201382.","journal-title":"J Infect Dis"},{"key":"3234_CR67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-9378-6-15","volume":"6","author":"K Wakeham","year":"2011","unstructured":"Wakeham K, et al. Parasite infection is associated with Kaposi\u2019s sarcoma associated herpesvirus (KSHV) in Ugandan women. Infect Agent Cancer. 2011;6:15.","journal-title":"Infect Agent Cancer"},{"issue":"603","key":"3234_CR68","first-page":"e9\u2013603.e15","volume":"21","author":"M Iaria","year":"2015","unstructured":"Iaria M, et al. Detection of KI WU and Merkel cell polyomavirus in respiratory tract of cystic fibrosis patients. Clin Microbiol Infect. 2015;21(603):e9\u2013603.e15.","journal-title":"Clin Microbiol Infect"},{"key":"3234_CR69","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2036.2004.01972.x","volume":"20","author":"H Murata","year":"2004","unstructured":"Murata H, et al. Helicobacter bilis infection in biliary tract cancer. Aliment Pharmacol Ther. 2004;20:90\u20134.","journal-title":"Aliment Pharmacol Ther"},{"key":"3234_CR70","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1128\/CVI.00132-08","volume":"15","author":"P Pisani","year":"2008","unstructured":"Pisani P, et al. Cross-reactivity between immune responses to Helicobacter bilis and Helicobacter pylori in a population in Thailand at high risk of developing cholangiocarcinoma. Clin Vaccine Immunol. 2008;15:1363\u20138.","journal-title":"Clin Vaccine Immunol"},{"key":"3234_CR71","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/vim.2005.18.267","volume":"18","author":"KL Mossman","year":"2005","unstructured":"Mossman KL, Ashkar ALIA. Review Herpesviruses and the innate immune response. Viral Immunol. 2005;18:267\u201381.","journal-title":"Viral Immunol"},{"key":"3234_CR72","volume-title":"Diseases and human evolution","author":"E Barnes","year":"2005","unstructured":"Barnes E. Diseases and human evolution. Albuquerque Univ: New Mex Press; 2005."},{"key":"3234_CR73","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1158\/1078-0432.CCR-12-3661","volume":"19","author":"K Oikonomopoulou","year":"2013","unstructured":"Oikonomopoulou K, Brinc D, Kyriacou K, Diamandis EP. Infection and cancer: revaluation of the hygiene hypothesis. Clin Cancer Res. 2013;19:2834\u201341.","journal-title":"Clin Cancer Res"},{"key":"3234_CR74","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1098\/rspb.2011.1697","volume":"279","author":"KR Smith","year":"2012","unstructured":"Smith KR, Hanson HA, Mineau GP, Buys SS. Effects of BRCA1 and BRCA2 mutations on female fertility. Proc Biol Sci. 2012;279:1389\u201395.","journal-title":"Proc Biol Sci"},{"key":"3234_CR75","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428\u201335.","journal-title":"Nature"},{"key":"3234_CR76","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/icb\/icl049","volume":"46","author":"K Lee","year":"2006","unstructured":"Lee K. A. Linking immune defenses and life history at the levels of the individual and the species. Integr Comp Biol. 2006;46:1000\u201315.","journal-title":"Integr Comp Biol"},{"key":"3234_CR77","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1289\/ehp.95103s8275","volume":"103","author":"B Walker","year":"1995","unstructured":"Walker B, Figgs LW, Zahm SH. Differences in cancer incidence, mortality, and survival between African Americans and whites. Environ Health Perspect. 1995;103:275\u201381.","journal-title":"Environ Health Perspect"},{"key":"3234_CR78","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(05)72656-8","volume":"356","author":"KJ O\u2019Byrne","year":"2000","unstructured":"O\u2019Byrne KJ, Dalgleish AG. Evolution, immune response, and cancer. Lancet. 2000;356:1033\u20134.","journal-title":"Lancet"},{"key":"3234_CR79","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/imr.12164","volume":"259","author":"CM Finlay","year":"2014","unstructured":"Finlay CM, Walsh KP, Mills KHG. Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases. Immunol Rev. 2014;259:206\u201330.","journal-title":"Immunol Rev"},{"key":"3234_CR80","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.urolonc.2009.09.017","volume":"29","author":"MC Botelho","year":"2015","unstructured":"Botelho MC, Oliveira PA, Lopes C, Correia da Costa JM, Machado JC. Urothelial dysplasia and inflammation induced by Schistosoma haematobium total antigen instillation in mice normal urothelium. Urol Oncol. 2015;29:809\u201314.","journal-title":"Urol Oncol"},{"key":"3234_CR81","doi-asserted-by":"crossref","first-page":"e8804","DOI":"10.1371\/journal.pone.0008804","volume":"5","author":"S Perry","year":"2010","unstructured":"Perry S, et al. Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One. 2010;5:e8804.","journal-title":"PLoS One"},{"key":"3234_CR82","doi-asserted-by":"crossref","unstructured":"Gillespie SH. Tuberculosis: evolution in millennia and minutes. Biochemical Society Transactions. 2007;35:9\u201312.","DOI":"10.1042\/BST0351317"},{"key":"3234_CR83","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/1940-6207.CAPR-08-0170","volume":"1","author":"MJ Blaser","year":"2008","unstructured":"Blaser MJ. Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma. Cancer Prev Res (Phila). 2008;1:308\u201311.","journal-title":"Cancer Prev Res (Phila)"},{"key":"3234_CR84","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nrc3610","volume":"13","author":"RF Schwabe","year":"2013","unstructured":"Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer. 2013;13:800\u201312.","journal-title":"Nat Rev Cancer"},{"key":"3234_CR85","volume-title":"The killer within","author":"H Ledford","year":"2014","unstructured":"Ledford, H. The killer within. (2014)."},{"key":"3234_CR86","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","volume":"480","author":"I Mellman","year":"2011","unstructured":"Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature. 2011;480:480\u20139.","journal-title":"Nature"},{"key":"3234_CR87","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc3770","volume":"14","author":"BD Lichty","year":"2014","unstructured":"Lichty BD, Breitbach CJ, Stojdl DF, Bell JC. Going viral with cancer immunotherapy. Nat Rev Cancer. 2014;14:559\u201367.","journal-title":"Nat Rev Cancer"},{"key":"3234_CR88","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.imbio.2014.09.002","volume":"220","author":"H Qi","year":"2015","unstructured":"Qi H, et al. Therapeutic efficacy of IL-17A antibody injection in preventing the development of colitis associated carcinogenesis in mice. Immunobiology. 2015;220:54\u20139.","journal-title":"Immunobiology"},{"key":"3234_CR89","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1038\/sj.onc.1207751","volume":"23","author":"EE Calle","year":"2004","unstructured":"Calle EE, Thun MJ. Obesity and cancer. Oncogene. 2004;23:6365\u201378.","journal-title":"Oncogene"},{"key":"3234_CR90","first-page":"97","volume":"12","author":"MH Mostafa","year":"1999","unstructured":"Mostafa MH, Sheweita SA. Relationship between Schistosomiasis and Bladder Cancer Evidence Supporting The Relationship Between Schistosomiasis And Bladder. 1999;12:97\u2013111.","journal-title":"Relationship between Schistosomiasis and Bladder Cancer Evidence Supporting The Relationship Between Schistosomiasis And Bladder"},{"key":"3234_CR91","doi-asserted-by":"crossref","unstructured":"Choi BI, Han JK, Hong ST, Lee KH. Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis. Clin Microbiol Rev. 2004;17:540\u201352.\u00a0","DOI":"10.1128\/CMR.17.3.540-552.2004"},{"key":"3234_CR92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2009.06.001","volume":"392","author":"H Zur Hausen","year":"2009","unstructured":"Zur Hausen H. The search for infectious causes of human cancers: where and why. Virology. 2009;392:1\u201310.","journal-title":"Virology"},{"key":"3234_CR93","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jare.2013.07.007","volume":"6","author":"RK Aziz","year":"2013","unstructured":"Aziz RK, Khalifa MM, Sharaf RR. Contaminated water as a source of Helicobacter pylori infection. J Adv Res. 2013;6:539\u201347.","journal-title":"J Adv Res"},{"key":"3234_CR94","doi-asserted-by":"crossref","unstructured":"Ewald PW, Swain Ewald HA. Infection, mutation, and cancer evolution. J Mol Med (Berl). 2012;90:535\u201341.","DOI":"10.1007\/s00109-012-0891-2"},{"key":"3234_CR95","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","volume":"118","author":"DM Parkin","year":"2006","unstructured":"Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030\u201344.","journal-title":"Int J Cancer"},{"key":"3234_CR96","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","volume":"13","author":"C De Martel","year":"2012","unstructured":"De Martel C, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13:607\u201315.","journal-title":"Lancet Oncol"},{"key":"3234_CR97","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","volume":"30","author":"SJ Russell","year":"2012","unstructured":"Russell SJ, Peng K-W, Bell JC. Oncolytic virotherapy. Nat Biotechnol. 2012;30:658\u201370.","journal-title":"Nat Biotechnol"},{"key":"3234_CR98","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chom.2014.01.002","volume":"15","author":"J Bell","year":"2014","unstructured":"Bell J, McFadden G. Viruses for tumor therapy. Cell Host Microbe. 2014;15:260\u20135.","journal-title":"Cell Host Microbe"},{"key":"3234_CR99","doi-asserted-by":"crossref","unstructured":"Ledford H. Cancer-fighting viruses near market. Nature. 2015;526","DOI":"10.1038\/526622a"},{"key":"3234_CR100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/156652409788167113","volume":"9","author":"Y Kim","year":"2010","unstructured":"Kim Y, Lin Q, Glazer PM, Yun Z. Hypoxic tumor microenvironment and cancer cell differentiation. Curr Mol Med. 2010;9:425\u201334.","journal-title":"Curr Mol Med"},{"key":"3234_CR101","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.0406242101","volume":"101","author":"N Agrawal","year":"2004","unstructured":"Agrawal N, et al. Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A. 2004;101:15172\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3234_CR102","doi-asserted-by":"crossref","first-page":"249ra111","DOI":"10.1126\/scitranslmed.3008982","volume":"6","author":"NJ Roberts","year":"2014","unstructured":"Roberts NJ, et al. Intratumoral injection of clostridium novyi-NT spores induces antitumor responses. Sci. Transl Med. 2014;6:249ra111.","journal-title":"Transl Med"},{"key":"3234_CR103","doi-asserted-by":"crossref","unstructured":"Palefsky JM, Holly EA. Chapter 6: Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr. 2003;31:5\u201310.","DOI":"10.1093\/oxfordjournals.jncimonographs.a003481"},{"key":"3234_CR104","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1200\/JCO.2013.53.1376","volume":"32","author":"S Gopal","year":"2014","unstructured":"Gopal S, et al. Moving forward in HIV-associated cancer. J Clin Oncol. 2014;32:876\u201380.","journal-title":"J Clin Oncol"},{"key":"3234_CR105","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrc2888","volume":"10","author":"EA Mesri","year":"2010","unstructured":"Mesri EA, Cesarman E, Boshoff C. Kaposi\u2018s sarcoma and its associated herpesvirus. Nat Rev Cancer. 2010;10:707\u201319.","journal-title":"Nat Rev Cancer"},{"key":"3234_CR106","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bpobgyn.2004.10.002","volume":"19","author":"ZM Chirenje","year":"2005","unstructured":"Chirenje ZM. HIV and cancer of the cervix. Best Pract Res Clin Obstet Gynaecol. 2005;19:269\u201376.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"3234_CR107","doi-asserted-by":"publisher","unstructured":"Gur, C. et al. Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack. Immunity 344\u2013355 (2015). doi: 10.1016\/j.immuni.2015.01.010","DOI":"10.1016\/j.immuni.2015.01.010"},{"key":"3234_CR108","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/JVI.76.3.1285-1292.2002","volume":"76","author":"JV Spencer","year":"2002","unstructured":"Spencer JV, et al. Potent immunosuppressive activities of cytomegalovirus- encoded interleukin-10. J Virol. 2002;76:1285\u201392.","journal-title":"J Virol"},{"key":"3234_CR109","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2042-4280-2-10","volume":"2","author":"CS Cobbs","year":"2011","unstructured":"Cobbs CS. Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis. Herpesviridae. 2011;2:10.","journal-title":"Herpesviridae"},{"key":"3234_CR110","doi-asserted-by":"crossref","unstructured":"Coley WB. The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the streptococcus erysipelas and the Bacillus Prodigiosus). 1909.","DOI":"10.1177\/003591571000301601"},{"key":"3234_CR111","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749\u201359.","journal-title":"Nat Rev Immunol"},{"key":"3234_CR112","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.eururo.2009.11.023","volume":"57","author":"P Gontero","year":"2010","unstructured":"Gontero P, et al. The role of bacillus Calmette-Gu\u00e9rin in the treatment of non-muscle-invasive bladder cancer. Eur Urol. 2010;57:410\u201329.","journal-title":"Eur Urol"},{"key":"3234_CR113","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3892\/etm.2014.2060","volume":"9","author":"P Huang","year":"2015","unstructured":"Huang P, et al. Efficacy of intravesical bacillus Calmette-Gu\u00e9rin therapy against tumor immune escape in an orthotopic model of bladder cancer. Exp Ther Med. 2015;9:162\u20136.","journal-title":"Exp Ther Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3234-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T11:56:23Z","timestamp":1658922983000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3234-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,12]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3234"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3234-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,12]]},"article-number":"257"}}